Syndax Pharmaceuticals Inc. has announced the granting of inducement awards as part of its 2023 Inducement Plan. Effective July 1, 2025, the company has provided stock options to purchase up to 228,400 shares of common stock to 14 new employees. These options will vest over a period of four years, with an initial 25% of the shares vesting on the first anniversary of the vesting commencement date. Thereafter, 1/48th of the shares will vest monthly over the following 36 months, contingent on the employees' continued service with the company.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Syndax Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9487031-en) on July 02, 2025, and is solely responsible for the information contained therein.